NCT06872723

Brief Summary

To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
340

participants targeted

Target at P75+ for all trials

Timeline
58mo left

Started Mar 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Mar 2025Feb 2031

First Submitted

Initial submission to the registry

March 6, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

March 21, 2025

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2029

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2031

Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

3.9 years

First QC Date

March 6, 2025

Last Update Submit

March 31, 2025

Conditions

Lung Cancer Screening

Outcome Measures

Primary Outcomes (1)

  • Safety and Adverse Events (AEs)

    Through study completion; an average of 1 year.

Study Arms (1)

Lung Cancer Screening

Participants who agree to take part in this study, will participate in an interview. During the interview, participants may be asked about: * Participants background information, such as your race and level of education * Participants lung cancer diagnosis and your history of lung cancer screening * Participants experience with scheduling lung cancer screening * Any barriers that kept participants from completing screening

Behavioral: Lung Cancer Screening

Interventions

Lung Cancer ScreeningBEHAVIORAL

Participants who agree to take part in this study, will participate in an interview. During the interview, participants may be asked about: • Participants background information, such as your race and level of education • Participants lung cancer diagnosis and your history of lung cancer screening • Participants experience with scheduling lung cancer screening • Any barriers that kept participants from completing screening

Lung Cancer Screening

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

You may qualify if:

  • Current smoker or quit within the past 15 years
  • A 20+ pack-year smoking history
  • Healthy enough for treatment

You may not qualify if:

  • Not applicable as our focus is on patients with an order for screening at the UTMB or UT Tyler

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

Study Officials

  • Robert Volk, PHD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Robert Volk, PHD

CONTACT

713-563-2509bvolk@mdanderson.org

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2025

First Posted

March 12, 2025

Study Start

March 21, 2025

Primary Completion (Estimated)

February 28, 2029

Study Completion (Estimated)

February 28, 2031

Last Updated

April 2, 2025

Record last verified: 2025-03

Locations

US(1)